Global /South Korea /Healthcare /Medical Devices /363250

Genesystem Co., Ltd.

363250

• KRX: 363250 • Delayed

5,510KRW 0.2%

3.61 USD

As of 13 June 2026, Genesystem Co., Ltd. has a market cap of $27.43M USD, ranking #34862 globally and #2169 in South Korea. It ranks #3143 in the Healthcare sector, and #670 in the Medical Devices industry.

Global Rank

34862

Country Rank

2169

Sector Rank

3143

Industry Rank

670

Key Stats

Market Cap

$27.43MUSD

41.72B KRW

Enterprise Value

$28.69MUSD

43.78B KRW

Revenue (TTM)

$250.76KUSD

381.36M KRW

EBITDA (TTM)

-$5.68MUSD

-8.67B KRW

Net Income (TTM)

-$7.86MUSD

-11.96B KRW

PS Ratio

109.4

PB Ratio

5.4

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Devices

Employees

Founded

2010

Website

genesystem.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.2%	-4.7%	-16%	1.1%	-10%	34%	-45%	-68%	-75%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	363250 진시스템 ISIN: KR7363250002 Shares Out.: Shares Outstanding: 8.286M¹ Shares Float: 6.774M² TV: TradingView: KRX: 363250 SA: Stock Analysis: KRX: 363250 YF: Yahoo Finance: 363250.KS GF: Google Finance: KRX: 363250 BA: Barron's: 363250 MS: Morningstar: XKRX: 363250	5,510 KRW	TV: TradingView: KRX: 363250 SA: Stock Analysis: KRX: 363250 YF: Yahoo Finance: 363250.KS GF: Google Finance: KRX: 363250 BA: Barron's: 363250 MS: Morningstar: XKRX: 363250

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Genesystem Co., Ltd.

Genesystem Co., Ltd., a biotech engineering company, specializes in molecular testing solutions to target on-site testing needs. The company offers PCR systems, multiplex biochips, and PCR reagents. It also provides human pathogen assays, including novel coronavirus (SARS-CoV-2) detection kits, SARS-CoV-2/Flu/RSV simultaneous detection kits, and mycobacterium tuberculosis detection kits; veterinary diagnostics; food safety assays comprising foodborne pathogen detection kits, HALAL food testing kits, and meat species identification kits; and nucleic acid extraction assays, such as extraction kits, extraction buffers, lysis buffers, and gDNA extraction kits. The company was incorporated in 2010 and is based in Daejeon, South Korea.

Similar Companies

Industry: Medical Devices (South Korea)

Name	Market Cap (USD) diff.	PE	Country
CLASSYS Inc. KRX: 214150	$2.47B 3.75T KRW 9K%	28.7	South Korea
SEERS Co., Ltd. KRX: 458870	$1.23B 1.86T KRW 4K%	114.8	South Korea
Livsmed Inc. KRX: 491000	$1.19B 1.81T KRW 4K%	-	South Korea
L&C BIO Co.,LTD KRX: 290650	$1.14B 1.74T KRW 4K%	-	South Korea
Seegene, Inc. KRX: 096530	$759.58M 1.16T KRW 3K%	23.9	South Korea
i3system Inc. KRX: 214430	$532.37M 809.64B KRW 2K%	83.3	South Korea

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 632K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 586K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 580K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 461K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 440K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 371K%	22.2	Ireland

chevron_leftBack